Ingrid Wybo
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 29
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 15
- Endocrinology top 1%
- Diphtheria, Corynebacterium, and Tetanus 6
-
- Antibiotic Use and Resistance 8
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research 7
-
- Streptococcal Infections and Treatments 16
-
- Infective Endocarditis Diagnosis and Management 12
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Co-authors
- Denis PiérardOriane SoetensKristof VandoorslaerAnne DedisteOlivier VandenbergFedoua EchahidiDelphine MartinyLaurent Busson
In The Last Decade
Ingrid Wybo
60 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Clinical Biochemistry 649
- Molecular Medicine 350
- Endocrinology 323
- Applied Microbiology and Biotechnology 118
- Infectious Diseases 311
Countries citing papers authored by Ingrid Wybo
This map shows the geographic impact of Ingrid Wybo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Wybo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Wybo more than expected).
Fields of papers citing papers by Ingrid Wybo
This network shows the impact of papers produced by Ingrid Wybo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Wybo. The network helps show where Ingrid Wybo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ingrid Wybo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 26 | |
| 9 | 2019 | 37 | |
| 10 | 2019 | 5 | |
| 11 | 2018 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2018 | 29 | |
| 14 | 2017 | 9 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 44 | |
| 17 | 2016 | 15 | |
| 18 | 2013 | 8 | |
| 19 | 2009 | 25 | |
| 20 | 2003 | 4 |
About Ingrid Wybo
Ingrid Wybo is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (29 papers), Streptococcal Infections and Treatments (16 papers), Antibiotic Resistance in Bacteria (15 papers), Infective Endocarditis Diagnosis and Management (12 papers), Antibiotic Use and Resistance (8 papers), Clostridium difficile and Clostridium perfringens research (7 papers), Diphtheria, Corynebacterium, and Tetanus (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Clinical Biochemistry (649 citations), Molecular Medicine (350 citations) and Endocrinology (323 citations). Ingrid Wybo has collaborated with scholars based in Belgium, France and Hungary. Frequent co-authors include Denis Piérard, Oriane Soetens, Kristof Vandoorslaer, Anne Dediste, Olivier Vandenberg, Fedoua Echahidi, Delphine Martiny, Laurent Busson, Deborah De Geyter and Y. Glupczynski. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Hospital Infection, International Journal of Antimicrobial Agents, Diagnostic Microbiology and Infectious Disease and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.